NCT04611659View on ClinicalTrials.gov

Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine

NAUnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

October 31, 2021

Conditions
Opioid-use DisorderContraceptionNeonatal Abstinence Syndrome
Interventions
BEHAVIORAL

Motivational Interviewing and Educational Training (MIET)

Women in the intervention arm will receive a motivational interviewing intervention coupled with education on contraception and the potential for neonatal abstinence syndrome.

Trial Locations (1)

37208

Meharry Medical College, Nashville

Sponsors
All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

Meharry Medical College

OTHER

NCT04611659 - Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine | Biotech Hunter | Biotech Hunter